228 related articles for article (PubMed ID: 9270035)
1. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
2. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
5. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1.
Ono M; Morisawa K; Nie J; Ota K; Taniguchi T; Saibara T; Onishi S
Cancer Res; 1998 May; 58(9):1813-6. PubMed ID: 9581818
[TBL] [Abstract][Full Text] [Related]
8. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
10. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
11. Target cell populations in virus-associated hepatocarcinogenesis.
Thorgeirsson SS
Princess Takamatsu Symp; 1995; 25():163-70. PubMed ID: 8875621
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
[TBL] [Abstract][Full Text] [Related]
13. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.
Huang SN; Chisari FV
Hepatology; 1995 Mar; 21(3):620-6. PubMed ID: 7875658
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
Laird AD; Brown PI; Fausto N
Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155
[TBL] [Abstract][Full Text] [Related]
15. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
[TBL] [Abstract][Full Text] [Related]
16. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
Dunsford HA; Sell S; Chisari FV
Cancer Res; 1990 Jun; 50(11):3400-7. PubMed ID: 1692259
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.
Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K
Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF; Thorgeirsson SS
Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
Factor VM; Jensen MR; Thorgeirsson SS
Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
[TBL] [Abstract][Full Text] [Related]
20. Development of liver tumors in transforming growth factor alpha transgenic mice.
Lee GH; Merlino G; Fausto N
Cancer Res; 1992 Oct; 52(19):5162-70. PubMed ID: 1327502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]